Clinical Laserthermia
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheelevägen 2, Lund, Skane, 223 81, Swe...Phone Number
+46 46152100Website
www.clinicallaser.seRevenue
<$5 MillionStock Symbol
CLS-BTA-B.STIndustry
About Clinical Laserthermia
Is Clinical Laserthermia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Clinical Laserthermia has new funding data
Website visits: Recent activity has been detected on your website
Clinical Laserthermia, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Clinical Laserthermia recently announced quarterly report
Click to see if Clinical Laserthermia had a recent Job posting/layoffs
Check out if Clinical Laserthermia is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Clinical Laserthermia
Check if Clinical Laserthermia has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Clinical Laserthermia launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Clinical Laserthermia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Clinical Laserthermia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Clinical Laserthermia.
Clinical Laserthermia Tech Stack
A closer look at the technologies used by Clinical Laserthermia
Most Recent Scoops
Clinical Laserthermia News & Media
Correction: Clinical Laserthermia Systems nomination committee appointed
The press release as of December 22, 2023 regarding the appointment of Nomination Committee of Clinical Laserthermia Systems AB (the "Company" or CLS") in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 29, 2023, incorrectly stated Lars-Erik T. Eriksson as a member of the Committee, representing Elano AB. The correct member is Hans von Celsing, representing himself. Furthermore, Henrik Nilsson was incorrectly stated as representing himselClinical Laserthermia Systems nomination committee appointed
The Nomination Committee of Clinical Laserthermia Systems AB (the "Company" or CLS") has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on 29 June 2023. Members of the Nomination Committee The following persons have been appointed members of the Nomination Committee for the 2024 Annual General Meeting: 1. Karl-Göran Tranberg, representing KG Tranberg Medical AB – owner of class A shares. 2. Lars-Erik T. Eriksson, representingBulletin from the Extraordinary General Meeting on Thursday 8 June in Clinical Laserthermia Systems AB
Today, June 8, 2023, an Extraordinary General Meeting was held in Clinical Laserthermia Systems AB, org. no. 556705–8903. Below is a summary of the decisions taken. All decisions were taken with the required majority. Resolution to amend the Articles of Association The Extraordinary General Meeting resolved to amend the Articles of Association in accordance with the following alternatives, and to authorize the Board of Directors to register the Articles of Association that are best suited
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Clinical Laserthermia
Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG® Thermal Therapy Systems, including ThermoguideTM Workstation and sterile disposables, for minimally invasive laser ablation of soft tissue, cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. CLS aims at expanding the current appr... Read More